Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between ANG Lifesciences IPO and Sagar Diamonds IPO.
ANG Lifesciences IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Sagar Diamonds IPO is a SME Book Built Issue proposed to list at BSE SME.
| ANG Lifesciences IPO | Sagar Diamonds IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Book Built Issue |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Guiness Corporate Advisors Pvt Ltd | Gretex Corporate Services Limited |
| Registrar | Bigshare Services Pvt Ltd | Bigshare Services Pvt Ltd |
| Market Maker | ||
| DRHP | DRHP  |
|
| RHP | RHP |
|
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of ANG Lifesciences IPO is up to ₹12.01 Cr whereas the issue size of the Sagar Diamonds IPO is . The final issue price of ANG Lifesciences IPO is ₹80.00 per share and of Sagar Diamonds IPO is .
| ANG Lifesciences IPO | Sagar Diamonds IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹40.00 per share | |
| Issue Price (Upper) | ₹45.00 per share | |
| Issue Price (Final) | ₹80.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 3000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 15,00,800 shares | 33,81,000 shares |
| Issue Size Total (Amount) | up to ₹12.01 Cr |
ANG Lifesciences IPO opens on Aug 29, 2017, while Sagar Diamonds IPO opens on Sep 14, 2017. The closing date of ANG Lifesciences IPO and Sagar Diamonds IPO is Aug 31, 2017, and Sep 18, 2017, respectively.
| ANG Lifesciences IPO | Sagar Diamonds IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 29, 2017 | Sep 14, 2017 |
| Issue Close | Aug 31, 2017 | Sep 18, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
ANG Lifesciences IPO P/E ratio is , as compared to Sagar Diamonds IPO P/E ratio of .
| ANG Lifesciences IPO | Sagar Diamonds IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the ANG Lifesciences IPO retail investors (RII) are offered 7,12,000 shares while in Sagar Diamonds IPO retail investors are offered 7,12,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in ANG Lifesciences IPO and in Sagar Diamonds IPO.
| ANG Lifesciences IPO | Sagar Diamonds IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | 0 shares | |
| NII | 7,12,000 shares | |
| RII | 7,12,000 shares | |
| Employee | ||
| Others | ||
| Total | 14,24,000 shares |
ANG Lifesciences IPO subscribed in total, whereas Sagar Diamonds IPO subscribed .
| ANG Lifesciences IPO | Sagar Diamonds IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
